Glatopa (Sandoz Inc)
Welcome to the PulseAid listing for the Glatopa drug offered from Sandoz Inc. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Sandoz Inc |
NON-PROPRIETARY NAME: | Glatiramer Acetate |
SUBSTANCE NAME: | GLATIRAMER ACETATE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | |
ROUTE: | SUBCUTANEOUS |
DOSAGE FORM: | INJECTION, SOLUTION |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2015-06-18 |
END MARKETING DATE: | 0000-00-00 |
Glatopa HUMAN PRESCRIPTION DRUG Details:
Item Description | Glatopa from Sandoz Inc |
LABELER NAME: | Sandoz Inc |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 20(mg/mL) |
START MARKETING DATE: | 2015-06-18 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0781-3234_c8eaa1ab-c679-47fc-a8d7-cb3280843df6 |
PRODUCT NDC: | 0781-3234 |
APPLICATION NUMBER: | ANDA090218 |
Other GLATIRAMER ACETATE Pharmaceutical Manufacturers / Labelers: